Investors 

A black cubic device with illuminated blue panels, featuring a circular white core and metallic prongs protruding from the top.

ReelReactor™ for Investors

ReelReactor is a new kind of continuous reactor for life science and chemistry. It replaces fragile batch steps with a steady, repeatable process that improves consistency and reduces contamination risk through a closed, single-use (disposable) path.

Why now

Industries are moving from batch to continuous to get better quality, faster timelines, and simpler scaling. ReelReactor is built for the time-sensitive steps that batch struggles to control.

    The Solution

    What we’re building

    A compact instrument plus single-use kits that make complex steps simple, clean, and repeatable—and easy to scale without redesigning the process.

  • Why we win

    Consistent results run after run

  • Cleaner operations with single-use paths

    Straightforward scale-up: add capacity as you grow

  • Fits existing workflows without major changes

A cylindrical mechanical device with metal rods, blue glowing rings, and four color-coded wires extending from one end.
Black and white image of a laboratory setup with a computer, medical fluid bags, and electronic equipment connected, possibly for a scientific or medical experiment.

    Validation & readiness

    Live demos and partner evaluations are available under NDA. Independent data and technical briefs are in our investor materials.

  • IP & moat

    Patents filed on the core design and methods; additional filings are planned.

  • Roadmap

    Pilot placements, scaling production of our single-use kits, and key hires to support early deployments.

Start Here

Get in touch

Disclaimer: This page is informational and not an offer to sell or a solicitation to buy securities. Any offering will be made only to qualified investors through official documents and in compliance with applicable laws. Forward-looking statements involve risks and uncertainties.

Stay Updated on ReelReactor™

Get the latest on our technology milestones, pilot placements, and investor opportunities.